Skip to main content
Oxford University Hospitals NHS Foundation Trust

Alert Coronavirus / COVID-19

If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).

Please find information on our services and visiting restrictions in our COVID-19 section.

Patients and visitors must wear a face covering in our hospitals.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

Myeloid disorders

  • Myelodysplasia (M82)
    Molecular investigations: myeloid panel (multi-target NGS panel (small variant))
    Karyotyping / FISH as outlined in the Test Directory
  • Aplastic Anaemia (M83)
    Karyotyping / FISH as outlined in the Test Directory
  • Chronic Neutrophilic Leukaemia (M87)
    Molecular investigations: myeloid panel (multi-target NGS panel (small variant) including CSF3R)
  • Juvenile Myelomonocytic Leukaemia (M88)
    Molecular investigations: myeloid panel (multi-target NGS panel (small variant))
  • Blastic Plasmacytoid Dendritic Cell Neoplasm (M90)
    Molecular investigations: myeloid panel (multi-target NGS panel (small variant) including CSF3R)

FLT3 internal tandem duplication analysis - targeted analysis for the FLT3 internal tandem duplication. Result has prognostic and treatment implications.